The New Nation - Internet Edition

BSS, Dhaka

The Union announced the successful results of a TB candidate-vaccine trial for people living with HIV (PLHIV) across the globe, according to message received here on Friday.

Investigators from Dartmouth Medical School (DMS) in the United States and Muhimbili University of Health and Allied Sciences (MUHAS) in Tanzania reported on the successful trial of a new vaccine against TB on Tuesday at the 39th World Conference on Lung Health in Paris.

The researchers described a placebo-controlled seven-year efficacy trial among 2,000 PLHIV showing that those who received the vaccine had a reduced rate of tuberculosis.

The research called "DarDar" study was conducted in Dar es Salaam, Tanzania under the supervision of Dr Lillian Mtei and Dr Kisali Pallangyo of MUHAS.